| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/02/2005 | WO2005049790A2 Skn-1 and gsk-3 genes and proteins |
| 06/02/2005 | WO2005049789A2 Synthetic mammalian retrotransposon gene |
| 06/02/2005 | WO2005049786A2 Modulation of angiogenesis by bartonella henselae |
| 06/02/2005 | WO2005049651A2 Cancer diagnosis and therapy |
| 06/02/2005 | WO2005049650A1 Lactoferrin polypeptide, process for producing the same and inflammation inducing substance |
| 06/02/2005 | WO2005049649A1 Process for the purification of il-18 binding protein |
| 06/02/2005 | WO2005049648A2 Chimeric or fusion constructs of insulin-like growth factor binding proteins as chemotherapeutic agents |
| 06/02/2005 | WO2005049647A2 Compositions comprising melittin-derved peptides and methods for the potentiation of immune responses against target antigens |
| 06/02/2005 | WO2005049646A2 “seedy1” nuceic acids for making plants having changed growth characteristics |
| 06/02/2005 | WO2005049645A1 Recovery of a heat shock protein |
| 06/02/2005 | WO2005049644A2 Tool for the transfer and production of proteins using the pseudomonas type iii secretion system |
| 06/02/2005 | WO2005049642A2 Genome of legionella pneumophila paris and lens strain-diagnostic and epidemiological applications |
| 06/02/2005 | WO2005049641A2 Surface-located campylobacter jejuni polypeptides |
| 06/02/2005 | WO2005049640A2 Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof |
| 06/02/2005 | WO2005049639A2 Compositions and methods for protein isolation |
| 06/02/2005 | WO2005049637A2 Methods for the isolation and purification of defensin polypeptides |
| 06/02/2005 | WO2005049099A2 Fibres embedded in a glassy protein |
| 06/02/2005 | WO2005049093A1 Use of microparticles for antigen delivery |
| 06/02/2005 | WO2005049092A1 Ocular tissue modification |
| 06/02/2005 | WO2005049084A2 Inhibition of trp channels as a treatment for cardiac hypertrophy and heart failure |
| 06/02/2005 | WO2005049075A2 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 06/02/2005 | WO2005049073A2 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 06/02/2005 | WO2005049072A2 Therapeutic cancer vaccine with fragments of trag-3 |
| 06/02/2005 | WO2005049067A1 Isolated complexes of endotoxin and md-2 |
| 06/02/2005 | WO2005048985A2 Alpha 1-antitrypsin compositions and treatment methods using such compositions |
| 06/02/2005 | WO2005048951A2 A novel human g-protein coupled receptor, hgprbmy8, expressed highly in brain |
| 06/02/2005 | WO2005048918A2 Anthrax vaccine |
| 06/02/2005 | WO2005048914A2 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases |
| 06/02/2005 | WO2005048913A2 Mutant lrp5/6 wnt-signaling receptors in cancer diagnosis, prognosis and treatment |
| 06/02/2005 | WO2005048693A2 Plant with improved drought tolerance |
| 06/02/2005 | WO2005033265A9 Optimized multi-epitope constructs and uses thereof |
| 06/02/2005 | WO2005030241A3 Treating inflammation using a biological agent that causes cells to release cytokine receptors |
| 06/02/2005 | WO2005025497A3 Hpv cd8+ t-cell epitopes |
| 06/02/2005 | WO2005023856A3 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof |
| 06/02/2005 | WO2005023852A3 Epilancin 15x lantibiotic |
| 06/02/2005 | WO2005018575A3 Estrogen receptor modulators and uses thereof |
| 06/02/2005 | WO2005018413A3 Methods, kits and antibodies for detecting parathyroid hormone |
| 06/02/2005 | WO2005017115A3 Cord blood-derived hematopoietic progenitor cells |
| 06/02/2005 | WO2005014836A3 Chimaeric vector system |
| 06/02/2005 | WO2005013889A9 Truncated fragments of alpha-synuclein in lewy body disease |
| 06/02/2005 | WO2005010027A3 Novel peptidic conjugates for alopecia preventive and curative treatment |
| 06/02/2005 | WO2005005637A3 Herpes simplex virus comprising a genetically modified glycoprotein d |
| 06/02/2005 | WO2005001099A8 Protein expression system |
| 06/02/2005 | WO2005000192A3 Glycogen synthase kinase-3 inhibitors |
| 06/02/2005 | WO2004112832A3 Immunogenic compositions comprising multiple gonococcal antigens |
| 06/02/2005 | WO2004112572A3 Monitoring immunologic, hematologic and inflammatory diseases |
| 06/02/2005 | WO2004110470A3 Use of collagen peptides to inhibit infection |
| 06/02/2005 | WO2004110384A3 Hiv-1 envelope glycoproteins having unusual disulfide structure |
| 06/02/2005 | WO2004104577A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 4 (5-ht4) |
| 06/02/2005 | WO2004104023A3 Metal chelate complexes immobilized on solid supports for peptide preparation |
| 06/02/2005 | WO2004103273A8 Inverse agonist and agonist peptides that stimulate/inhibit hair growth |
| 06/02/2005 | WO2004101741A3 Transgenic plants with increased glycine-betaine |
| 06/02/2005 | WO2004099781A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor rdc1 (rdc1) |
| 06/02/2005 | WO2004096136A3 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof |
| 06/02/2005 | WO2004092384A3 Means and methods for diagnosing and treating affective disorders |
| 06/02/2005 | WO2004087058A3 Targeted mhc class i alpha3 vaccine delivery systems |
| 06/02/2005 | WO2004083393A3 Enhanced protein thermostability and temperature resistance |
| 06/02/2005 | WO2004081187A3 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 06/02/2005 | WO2004078098A3 Peptides associated with hla-dr mhc class ii molecules involved in autoimmune diseases |
| 06/02/2005 | WO2004076633A3 Hypoxia inducible vegf plasmid for ischemic disease |
| 06/02/2005 | WO2004074507A8 Method to confer cell culture replication activity to different hepatitis c virus isolates |
| 06/02/2005 | WO2004074320A3 Therapeutic targets in cancer |
| 06/02/2005 | WO2004072242A3 Screening of compounds for hematological disorder treatment |
| 06/02/2005 | WO2004071414A3 Therapeutic anti-hcv (al9) compounds |
| 06/02/2005 | WO2004069163A3 Cross-protective epitopes of moraxella catarrhalis and use thereof |
| 06/02/2005 | WO2004065547A3 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 06/02/2005 | WO2004060310A8 Human growth hormone crystals and methods for preparing them |
| 06/02/2005 | WO2004055168A3 Il-21 production in prokaryotic hosts |
| 06/02/2005 | WO2004050860A3 Compositions, splice variants and methods relating to colon specific genes and proteins |
| 06/02/2005 | WO2004050853A3 Uses of the snorf55 receptor |
| 06/02/2005 | WO2004048521A3 Composition and method for treating lupus nephritis |
| 06/02/2005 | WO2004032614A3 Animal with modification of cytoplasmic dynein heavy chain 1 gene |
| 06/02/2005 | WO2004031358A3 Genetically engineered p30 antigen, improved antigen cocktail, and uses thereof |
| 06/02/2005 | WO2004030619A3 Protein s protects the nervous system from injury |
| 06/02/2005 | WO2004027034A3 Methods for assessing the ability of hiv patients to restrict hiv replication |
| 06/02/2005 | WO2004024894A3 Methods of modulating inflammation by administration of interleukin-19 and inhibitors of il-19 binding |
| 06/02/2005 | WO2004022576A3 Short peptides from the '2nd loop' of 7 transmembrane receptor which selectively modulate signal transduction |
| 06/02/2005 | WO2004013347A8 Methods of identifying compounds that modulate protein activity |
| 06/02/2005 | WO2004007689A3 Regulatory protein for nox enzymes |
| 06/02/2005 | WO2003090514A3 Adipocyte complement related protein zacrp14 |
| 06/02/2005 | WO2003087375A8 Cartilage differentiation regulating gene |
| 06/02/2005 | WO2003075847A3 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS |
| 06/02/2005 | WO2003059281A3 Novel variants of rankl protein |
| 06/02/2005 | WO2003057821A3 Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses |
| 06/02/2005 | US20050120417 Expression cassette with promoter operably linked to polynucleotide or complement encoding polypeptide comprising a basic helix-loop-helix domain, and complements an Arabidopsis ind1mutant phenotype; genetic engineering |
| 06/02/2005 | US20050120416 Using vector transformation to generate corn seeds homozygous for transgene which conferring artificial nuclear male sterility (AMS) and heterozygous for a fertility-restoring gene linked to a "small seed" phenotype; for use as tool in propagating recombinant plants of preferential phenotypes; bioreactor |
| 06/02/2005 | US20050120410 Nucleic acid sequences encoding the bos1 gene and promoter from arabidopisis thaliana and uses thereof |
| 06/02/2005 | US20050120409 Expression vector comprising nucleotide sequences coding hypersensitive response eliciting protein for use in generating disease, insect, drought and heat resistant plants; biological pest control |
| 06/02/2005 | US20050120408 Propagation of disease/herbicide/stress resistant plants; biological pest control |
| 06/02/2005 | US20050120398 Animal model for HCV infection |
| 06/02/2005 | US20050120397 Preventing spermatid differentiation via inhibition of caspase expression; gene expression inhibition; biological pest control; contraceptives; infertility treatment; male contraception |
| 06/02/2005 | US20050120393 Nucleotide sequences associated with prostate specific gene expression for use as tool in diagnosis, prognosis, classification, prevention and treatment of cell proliferative disorders of urogenital systems |
| 06/02/2005 | US20050120392 Using animal to identify modulators of blood coagulation; antithrombotic agents; identification and validation of platelet genes as targets for anti-thrombotic or thrombotic compounds |
| 06/02/2005 | US20050119472 GB virus C and methods of treating viral infections |
| 06/02/2005 | US20050119471 RNA viral sequences for use in development of vaccine to prevent gastrointestinal disorders in infants and young children |
| 06/02/2005 | US20050119465 Glycosylated follicle stimulating hormone for use as therapeutic tool in treatment of reproductive disorders |
| 06/02/2005 | US20050119464 Protein |
| 06/02/2005 | US20050119462 Expression vectors and promoters for heterologous gene expression |
| 06/02/2005 | US20050119461 Which have affinity for oxazoline compounds; for treatment of glaucoma, dementia, mood disturbances, degenerative conditions, and neurodegenerative diseases |
| 06/02/2005 | US20050119459 Expression vector comprising nucleotide sequences coding late-gestation lung 1 (LGL-1) for use as tool in diagnosis prevention and treatment of respiratory system disorders |